UBS AM’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-63,992
| Closed | -$9.67M | – | 2829 |
|
|
2022
Q3 | $9.67M | Sell |
63,992
-274,722
| -81% | -$41.5M | 0.01% | 971 |
|
|
2022
Q2 | $49.4M | Buy |
338,714
+278,098
| +459% | +$40.5M | 0.03% | 553 |
|
|
2022
Q1 | $7.19M | Buy |
60,616
+4,239
| +8% | +$503K | ﹤0.01% | 1197 |
|
|
2021
Q4 | $7.77M | Buy |
56,377
+1,460
| +3% | +$201K | ﹤0.01% | 1221 |
|
|
2021
Q3 | $7.63M | Buy |
54,917
+563
| +1% | +$78.2K | ﹤0.01% | 1194 |
|
|
2021
Q2 | $5.28M | Buy |
54,354
+2,251
| +4% | +$219K | ﹤0.01% | 1345 |
|
|
2021
Q1 | $3.56M | Buy |
52,103
+2,518
| +5% | +$172K | ﹤0.01% | 1500 |
|
|
2020
Q4 | $4.25M | Buy |
49,585
+4,627
| +10% | +$397K | ﹤0.01% | 1367 |
|
|
2020
Q3 | $2.92M | Buy |
44,958
+283
| +0.6% | +$18.4K | ﹤0.01% | 1381 |
|
|
2020
Q2 | $3.27M | Sell |
44,675
-6,445
| -13% | -$471K | ﹤0.01% | 1315 |
|
|
2020
Q1 | $1.74M | Sell |
51,120
-2,285
| -4% | -$77.8K | ﹤0.01% | 1470 |
|
|
2019
Q4 | $2.91M | Sell |
53,405
-140,353
| -72% | -$7.64M | ﹤0.01% | 1441 |
|
|
2019
Q3 | $8.08M | Buy |
193,758
+14,942
| +8% | +$623K | 0.01% | 1033 |
|
|
2019
Q2 | $7.83M | Buy |
178,816
+171,904
| +2,487% | +$7.53M | 0.01% | 1037 |
|
|
2019
Q1 | $356K | Hold |
6,912
| – | – | ﹤0.01% | 2243 |
|
|
2018
Q4 | $256K | Buy |
6,912
+312
| +5% | +$11.5K | ﹤0.01% | 2277 |
|
|
2018
Q3 | $248K | Buy |
+6,600
| New | +$248K | ﹤0.01% | 2349 |
|